IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.

Author statistics

Author Identifier Number of Items Total Downloads
Morokoff, A https://orcid.org/0000-0002-5159-3438 7 620

Items

Title Author(s) IrusType Repository Item URL Total Downloads
A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker orcid:0000-0002-3020-4245; orcid:0000-0001-5049-8861; orcid:0000-0002-5159-3438; Ma, C; Nguyen, HPT; Luwor, RB; Stylli, SS; Gogos, A; Paradiso, L; Kaye, AH; Morokoff, AP Article University of Melbourne [Minerva Access] http://hdl.handle.net/11343/220773 31
Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin orcid:0000-0002-0278-4801; orcid:0000-0002-8152-2120; orcid:0000-0001-5049-8861; orcid:0000-0002-5159-3438; Bennett, IE; Field, KM; Hovens, CM; Moffat, BA; Rosenthal, MA; Drummond, K; Kaye, AH; Morokoff, AP Article University of Melbourne [Minerva Access] http://hdl.handle.net/11343/219162 131
Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity orcid:0000-0002-7046-8392; orcid:0000-0002-9438-8055; orcid:0000-0002-5159-3438; orcid:0000-0003-3971-5380; Brown, DV; Filiz, G; Daniel, PM; Hollande, F; Dworkin, S; Amiridis, S; Kountouri, N; Ng, W; Morokoff, AP; Mantamadiotis, T Article University of Melbourne [Minerva Access] http://hdl.handle.net/11343/210753 31
Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib orcid:0000-0002-3505-7387; orcid:0000-0002-5159-3438; orcid:0000-0001-5049-8861; orcid:0000-0002-3020-4245; Areeb, Z; Stylli, SS; Ware, TMB; Harris, NC; Shukla, L; Shayan, R; Paradiso, L; Li, B; Morokoff, AP; Kaye, AH; Luwor, RB Article University of Melbourne [Minerva Access] http://hdl.handle.net/11343/220698 127
Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs orcid:0000-0002-5159-3438; orcid:0000-0002-3020-4245; orcid:0000-0001-5049-8861; orcid:0000-0003-3971-5380; orcid:0000-0002-3505-7387; Whitehead, CA; Nguyen, HPT; Morokoff, AP; Luwor, RB; Paradiso, L; Kaye, AH; Mantamadiotis, T; Stylli, SS Article University of Melbourne [Minerva Access] http://hdl.handle.net/11343/216434 48
MicroRNA as potential biomarkers in Glioblastoma orcid:0000-0002-3505-7387; orcid:0000-0002-5159-3438; orcid:0000-0001-5049-8861; orcid:0000-0002-3020-4245; Areeb, Z; Stylli, SS; Koldej, R; Ritchie, DS; Siegal, T; Morokoff, AP; Kaye, AH; Luwor, RB Article University of Melbourne [Minerva Access] http://hdl.handle.net/11343/220565 225
The role of interleukin-6-STAT3 signalling in glioblastoma orcid:0000-0002-5159-3438; orcid:0000-0001-5049-8861; orcid:0000-0002-3020-4245; West, AJ; Tsui, V; Stylli, SS; Nguyen, HPT; Morokoff, AP; Kaye, AH; Luwor, RB Article University of Melbourne [Minerva Access] http://hdl.handle.net/11343/220770 27
Jisc logo Cranfield logo CAVAL logo